3DI Stante B, Galandauer I, Aronow WS, et al. Prevalence of left ventricular diastolic dysfunction in obese persons with and without diabetes mellitus. Am J Cardiol,2005,95 : 1527-1528.
4Wang JJ, Taylor B, Wong TY, et aL Retinal vessel diameters and obesity: a population-based study in older persons. Obesity, 2006, 14:206-214.
5Bonnet F, Marre M, Halimi JM, et al. Larger waist circumference is a predictive factor for the occurrence of mieroalbuminuria in a non- diabetic population. Arch Mal Coeur Vaiss,2006,99: 660-662.
6Rodriguez WE, Tyagi N, Joshua IG, et al. Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus. Am J Physiol Renal Physiol, 2006,291: F694-F701.
7Lewis GF, Carpentier A, Adeli K, et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev, 2002,23:201-229.
8Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem, 1957, 226: 497-509.
9Ota M, Mori K, Nakashima A, et al. Resistance to excessive body weight gain in risperidone-injected rats. Clin Exp Pharmacol Physiol, 2005,32:279-287.
10Samuel VT, Liu ZX, Qu X, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem, 2004,279: 32345-32353.
